1. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug- eluting stent for left main registry (SP-DELFT) 
E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, N. Gonzalo, S. Cook, S. Marra, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, R. van Domburg, A. Colombo, I. Sheiban, P.W. Serruys 
International Journal of Cardiology 
Volume 137, Issue 1, Pages (September 2009)
DOI: /j.ijcard
Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1
Adjusted MACE-free survival curves and landmark analysis of the ostial/shaft (panel A), DISTAL-single (panel B), DISTAL-double (panel C) and whole DISTAL (panel D) groups. Solid lines, SES group; dotted lines, PES group; RR, PES-SES risk ratio with 95% confidence interval (in brackets). DaysOM, Days free from MACE. Landmark was positioned at 1 year (1y).
International Journal of Cardiology  , 16-21DOI: ( /j.ijcard )
Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions